Allergy Medicine
T cells induced by Foxp3-retrovirus infection control contact allergy
Published in Vaccine Weekly, October 19th, 2005
"Regulatory T cells are promising candidates for the modulation of inflammation and autoimmunity. To generate regulatory T cells in vitro, we have infected naive CD4+ CD25 T cells with a retrovirus encoding the transcription factor Foxp3. Foxp3-infected T cells are similar to naturally occurring regulatory T cells as evidenced by surface marker expression and function. To investigate the effects of Foxp3-infected T cells on contact hypersensitivity (CHS) responses, sensitized mice were injected with Foxp3-or control virus-infected T...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-10-19)
More Articles from Vaccine Weekly
- Ascaris Vaccine Development
Ascaris suum antigen protects against Ascaris lung infection - Drug Development
Monoclonal antibody combination neutralizes natural rabies virus variants - Leukemia Vaccine Development
Dendritic cell vaccine shows promise for chronic lymphocytic leukemia - Measles-Mumps-Rubella-Varicella Vaccine
Dose response of children to measles, mumps, rubella and varicella vaccine tested - Metapneumovirus Vaccine Development
Cotton rat is model of human metapneumovirus infection and immunity - Allergy Vaccine Development
Th1 directing adjuvants suppress allergen-induced T-helper responses - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
